The European Patent Office (EPO) has granted patent EP3474869B1, titled "HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF." This patent, designated with the publication kind B1, was granted on March 18, 2026. It covers compositions derived from human tissue and their various applications, with specific IPC classifications indicating relevance to medicinal preparations, cell culture, and biological material preservation.

This grant represents the finalization of the patent process for this specific invention within the designated European states. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in research and development related to tissue-derived products, should note this granted patent as it may impact their intellectual property landscape and freedom to operate in these specific areas. No immediate compliance actions are required for entities outside of those directly involved in the patent's scope or seeking to utilize the patented technology.